Technicals Say Exelixis Inc. (EXEL) Is Worth Holding

As of Friday close, Exelixis Inc.’s (NASDAQ:EXEL) stock was up $0.28, moving up 1.41 percent to $20.08. The average number of shares traded per day over the past five days has been 3,852,320 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.41 fall in that time frame. In the last twenty days, the average volume was 2,322,785, while in the previous 50 days, it was 2,074,082.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, EXEL stock retreated -12.66%. Shares of the company fell to $19.01 on 05/11/22, the lowest level in the past month. A 52-week high of $25.77 was reached on 04/05/22 after having rallying from a 52-week low of $15.50. Since the beginning of this year, EXEL’s stock price has risen by 9.85% or $1.80, and marked a new high 22 times. However, the stock has declined by -22.08% since its 52-week high.

Exelixis Inc. (EXEL) last reported insider trading activity 2 days ago on May 12. WILLSEY LANCE, the Director of the company, disposed of 40,000 shares for $19.65 on May 12. It resulted in a $786,000 divestment by the insider. WYSZOMIERSKI JACK L sold 6,696 shares at an average price of $23.00 on Apr 04. The insider now owns 273,192 shares following the transaction. On Apr 01, EVP, Commercial Haley Patrick J. sold 10,000 shares at $23.00 apiece. The transaction was valued at $230,000.

Valuation Metrics

Right now, Exelixis Inc. (EXEL) has a P/E ratio of about 28.04. The stock’s beta is 0.75. Besides these, the trailing price-to-sales (P/S) ratio of 4.65, the price-to-book (PB) ratio of 2.89, and the price-to-cash flow ratio of 19.81 may also be considered.

Financial Health

In the three months ended September 29, Exelixis Inc.’s quick ratio stood at 5.40, while its current ratio was 5.40, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 96.30% percent. In the year ended September 29, operating margins totaled 20.00%. Based on annual data, EXEL earned $1.38 billion in gross profit and brought in $1.43 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 10.10%. Return on equity (ROE) for the past 12 months was 11.20%.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. EXEL’s revenue rose 24.09% to $451.14 million during the quarter, while net income inched up to $355.98 million. While analysts expected Exelixis Inc. to report $0.17 quarterly earnings, the actual figure was $0.12 per share, beating the consensus estimate by -29.40%. During the quarter, the company generated $87.73 million in EBITDA. The liabilities of Exelixis Inc. were 360.27 million at the end of its most recent quarter ended September 29, and its total debt was $52.25 million. The value of shareholders’ equity is $320.74 million.

Technical Picture

This quick technical analysis looks at Exelixis Inc.’s (EXEL) price momentum. With a historical volatility rate of 57.47%, the RSI 9-day stood at 32.64% on 13 May.

With respect to its five-day moving average, the current Exelixis Inc. price is down by -6.56% percent or -$1.41. At present, EXEL shares trade -13.04% below its 20-day simple moving average and +7.49% percent above its 100-day simple moving average. However, the stock is currently trading approximately -4.65% below its SMA50 and +19.10% above its SMA200.

Stochastic coefficient K was 21.76% and Stochastic coefficient D was 17.29%, while ATR was 0.86. Given the Stochastic reading of 25.97% for the 14-day period, the RSI (14) reading has been calculated as 36.00%. As of today, the MACD Oscillator reading stands at -0.98, while the 14-day reading stands at -1.57.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles